Home > What we do > Medicine & Healthcare > hMedicine > hMedicine Story

Abandoned Baby Receives Life-Saving Heart Surgery at Hadassah

Dr. Eldad Erez

When "Rami," just a few days old, was found in a box on a street in Bethlehem, someone brought him to the Bethlehem Creche, a nearby orphanage. Born with a serious heart problem, he was referred to Hadassah Hospital-Ein Kerem for life-saving surgery and now is recovering in the Pediatric Intensive Care Unit (PICU).

The nuns at the Creche first brought the baby to Bethlehem's Caritas Baby Hospital, where physicians diagnosed a coarctation of the aorta (a narrowing of the major blood vessel that carries blood from the heart to the body). Without corrective surgery, they knew he would die.

"I received a call from the cardiologist and we said we'd find space for him as soon as possible," relates Hadassah Pediatric Cardiothoracic Surgeon Dr. Eldad Erez. "In a newborn, the heart is the size of his fist," he explains. "We plan out the surgery ahead of time and try to be as precise as possible."

Dr. Erez reports that, following this successful surgery, Rami's prognosis is excellent. He adds: "I'm a father of four and, as a dad, I feel particularly happy that a child who has started his life with the double obstacles of abandonment and a congenital heart defect will have a chance at a normal life."

Read more>>

We are committed to preventing, diagnosing, treating, and continuing the research that could one day eradicate heart disease. For decades, Hadassah Medical Organization has been at the forefront of innovative heart research in the Middle East.

DONATE

Join

Advocate

Lead

LEARN MORE

View all of our Impact Areas


Date: 12/9/2013


More hMedicine Stories




Hadasit, Hadassah’s Technology Transfer Arm, Reviews 2012’s Accomplishments

When the Hadassah University Medical Center’s physicians suggest a solution to a medical problem which can lead to the development of a new medicine or product, Hadasit, Hadassah’s technology transfer arm, explores its feasibility and supports the promotion of those viable ideas with innovation potential. Although 2012 has been “a year full of challenges for the life science industry,” says Einat Zisman, Hadasit’s Chief Executive Officer, Hadasit still signed 125 agreements for clinical trials, all to be done at Hadassah. In addition, Hadasit signed 15 agreements for cooperation and commercialization of technologies that were developed at Hadassah. Click here to read the latest Newsletter from Hadasit >>

   |  Who We Are  |  What We Do  |  Where We Do It  |  Read About It  |  Join Now  |  Donate  |
  |  Login  |  Contact Us  |  Careers  |  Terms & Conditions  |  
Copyright ©2014 Hadassah is a registered trademark of Hadassah, the Women's Zionist Organization of America